Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 783 Carcinoma, Non-Small-Cell Lung 170 Skin Neoplasms 154 Neoplasms 106 Neoplasm Metastasis 100 Colorectal Neoplasms 97 Carcinoma, Renal Cell 95 Uveal Melanoma 92 Breast Neoplasms 88 Squamous Cell Carcinoma of Head and Neck 85 Carcinoma, Basal Cell 83 Lung Neoplasms 81 Ovarian Neoplasms 79 Sarcoma 67 Lymphoma, T-Cell, Cutaneous 66 Carcinoma, Merkel Cell 66 Stomach Neoplasms 58 Pancreatic Neoplasms 58 Head and Neck Neoplasms 55 Carcinoma, Hepatocellular 53 Uterine Cervical Neoplasms 52 Urinary Bladder Neoplasms 50 Esophageal Neoplasms 44 Prostatic Neoplasms 43 Triple Negative Breast Neoplasms 42 Endometrial Neoplasms 41 Carcinoma, Squamous Cell 39 Brain Neoplasms 39 Carcinoma, Transitional Cell 37 Lymphoma 35

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fever × Dermatologic × 1 year × Clear all

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡